Understanding a product's purpose, ingredient claims, and ventilation guidance can make nail care questions easier to ask. This guide explains the statements from FDA and OSHA in plain language.
Nail product questions begin with a simple distinction: what is the product intended to do? The U.S. Food and Drug Administration (FDA) says nail products for home and salon use are generally regulated as cosmetics under the Federal Food, Drug, and Cosmetic Act. Products intended to treat medical problems, such as nail fungus, are drugs. The agency's explanation covers products used at home as well as those used in a salon.
When comparing products, read the stated purpose alongside the shade, finish, or design description. A question about a possible medical problem is a reason to seek advice from a clinician. Keep that question separate from choosing a cosmetic look. Knowing the product's purpose helps you understand which part of FDA's explanation applies.
In its nail care product guidance, FDA says formaldehyde is an ingredient in some nail hardeners and polishes. It may appear on a label as "formalin" or "methylene glycol." FDA cautions that frequent use of these hardeners may make nails brittle and more likely to break or peel. The agency also says products containing formaldehyde may cause skin irritation and allergic reactions. These cautions are useful context when reading a hardener's label.
FDA identifies toluene as a solvent used in some polishes, hardeners, and removers, and says its use is being phased out. Read the information for the particular product being considered. The agency's statement describes a change in use across nail products; the ingredient information is where to start a question about an individual formula.
Artificial nail materials raise another ingredient question. FDA recounts injury complaints in the early 1970s involving methyl methacrylate (MMA) monomer. It removed products containing 100 percent MMA monomer through court proceedings. FDA says no regulation specifically prohibits MMA monomer in cosmetics, while the Occupational Safety and Health Administration (OSHA) notes that MMA artificial nail products are banned for use in many states. Keep the federal statement, product concentration, and state rules distinct when discussing an acrylic liquid.
OSHA's chemical hazards guidance explains that "3-free" products claim to be made without toluene, formaldehyde, and dibutyl phthalate, sometimes called the "toxic trio." It also explains that some primers labeled "acid free" claim to be made without chemicals such as methacrylic acid. Each phrase refers to a particular ingredient claim.
Use the terms as a starting point for reading the product information. "3-free" names three ingredients, while "acid free" describes a primer claim. Neither phrase gives you the rest of the formula. When discussing a design that involves several products, ask which label belongs to which product. A clear answer connects the term to the bottle or primer under discussion.
OSHA says workers' chemical exposures can add up, especially when many products are used at the same time, used day after day, or used with poor ventilation. It identifies ventilation as the best way to lower chemical levels in a salon. FDA also advises good ventilation when using nail products. Both agencies make the environment part of the product discussion.
OSHA cites NIOSH laboratory tests indicating that exhaust ventilation systems may reduce worker chemical exposure in nail salons by at least 50%. That finding concerns worker exposure in laboratory tests. It provides context for asking about exhaust ventilation, without predicting the exposure level during an individual visit.
OSHA's advice for ventilated tables includes keeping them turned on, changing charcoal filters at least monthly, and cleaning catch basins at least weekly. This makes maintenance a useful part of a question about ventilation. Ask how the equipment is used and maintained alongside questions about the products involved.
OSHA also describes Healthy Nail Salon Recognition Programs in several California counties and cities. These programs recognize salons that use less toxic polishes and other nail products, improve ventilation, and participate in training on workplace practices.
FDA describes the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) as the most significant expansion of its cosmetics authority since 1938. Its explanation sets out several responsibilities for businesses involved in making or marketing cosmetics. These responsibilities address facilities, product information, and records supporting safety.
According to FDA, manufacturers and processors must register facilities and renew registration every two years. A responsible person must list each marketed cosmetic product, including its ingredients, and provide annual updates. Facility registration concerns the manufacturing or processing location; product listing concerns the marketed product and its ingredient information.
FDA also says a responsible person must maintain records supporting adequate safety substantiation. Neither the law nor FDA regulations require specific tests for individual products or ingredients. Manufacturers may use relevant safety data already available, and animal testing is not required for marketing a cosmetic product. These details explain why a question about supporting safety information should focus on the records and evidence involved.
FDA says infections and allergic reactions can occur with some nail products and asks people who have a reaction to report it to the agency. Its guidance applies to home and salon products. Keep the product name and ingredient information available when discussing a concern; clear product details give the conversation a specific starting point.
Before a service, include known sensitivities in the discussion and ask which products are involved. For a concise explanation of label terms, see the Health & Safety FAQ. Use the ingredient and ventilation questions here to prepare for that discussion, and bring a question about a possible medical problem to a clinician.